Comparative pharmacologic effects on tissue factor activity in normal cells and an established cell line

Area of Science:

• Cell Biology
• Pharmacology
• Hematology

Background:

• Tissue factor (thromboplastin) is a key initiator of the coagulation cascade.
• Cellular expression of tissue factor is crucial for hemostasis and thrombosis.
• Exogenous drugs can modulate cellular functions, including coagulation factor expression.

Purpose of the Study:

• To investigate the differential effects of various drugs on tissue factor activity in distinct human cell types.
• To understand how cellular responses to drugs vary between fibroblasts, smooth muscle cells, epithelial cells, and endothelial cells.
• To explore the implications of these drug-induced modulations for cellular hemostatic function.

Main Methods:

• In vitro culture of human foreskin fibroblasts, umbilical vein smooth muscle cells, WISH cells, HeLa cells, and umbilical vein endothelial cells.
• Treatment of cell cultures with exogenous drugs including hydrocortisone, butyrate, colchicine, chloroquine, and vinblastine at specific concentrations.
• Assay of tissue factor (thromboplastin) activity in treated and untreated cells.

Main Results:

• Hydrocortisone and butyrate enhanced tissue factor activity in fibroblasts and smooth muscle cells, while colchicine suppressed it.
• WISH and HeLa cells showed increased activity with colchicine/chloroquine and decreased activity with hydrocortisone/high-dose butyrate.
• Umbilical vein endothelial cells exhibited unique responses, with chloroquine enhancing activity and butyrate suppressing it, while hydrocortisone and vinblastine had minimal effects.

Conclusions:

• Drug-induced modulation of tissue factor activity is cell-type specific.
• Endothelial cells display a distinct drug response profile, potentially contributing to their role as a hemostatic barrier.
• These findings highlight the complex interplay between pharmacology and cellular hemostasis.